SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001017491-16-000234
Filing Date
2016-11-08
Accepted
2016-11-08 16:28:13
Documents
59
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q apri9301610q.htm 10-Q 1089428
2 EXHIBIT 31.1 apri93016ex311.htm EX-31.1 11881
3 EXHIBIT 31.2 apri93016ex312.htm EX-31.2 11888
4 EXHIBIT 32.1 apri93016ex321.htm EX-32.1 5882
5 EXHIBIT 32.2 apri93016ex322.htm EX-32.2 5888
  Complete submission text file 0001017491-16-000234.txt   5550007

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT apri-20160930.xml EX-101.INS 981168
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT apri-20160930.xsd EX-101.SCH 47317
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT apri-20160930_cal.xml EX-101.CAL 62755
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT apri-20160930_def.xml EX-101.DEF 273376
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT apri-20160930_lab.xml EX-101.LAB 570625
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT apri-20160930_pre.xml EX-101.PRE 370585
Mailing Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130
Business Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130 (858) 222-8041
APRICUS BIOSCIENCES, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22245 | Film No.: 161981601
SIC: 2834 Pharmaceutical Preparations